Clinical Trial

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants

Terminated Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
Business objectives have changed
Summary
The purpose of this study is to evaluate the effect of Itraconazole and Rifampin on the drug levels of AR-LDD (BMS-986365) in healthy adult male participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-17; most recent amendment 2026-07-17.
Status change: Recruiting → Terminated 2026-07-17
Status change: Not Yet Recruiting → Recruiting 2025-12-18
Trial Details
NCT Number NCT07242781
Lead Sponsor Celgene
Conditions Healthy Volunteers
Enrollment 22 participants
Start Date 2025-12-15
Primary Completion 2026-04-09 (estimated)
Study Completion 2026-04-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-20